#MedicalAdvancements Archives - Page 2 of 3

ESMO in Five Minutes | Prof. Haitao Zhao : Highlights of Advances in the Treatment of Cholangiocarcinoma

By Mourabit Halima 2024.01.19

95MO: Efficacy of Tinengotinib in Treating Advanced Fibroblast Growth Factor Receptor (FGFR) Inhibitor Resistant/Recurrent Cholangiocarcinoma Patients Background Fibroblast Growth Factor Receptor inhibitors (FGFRi) have been shown to play a role…

ESMO 2023 | Professor Feng Jin: Less is More – New Evidence Added to Surgery Exemption After Neoadjuvant Therapy for Breast Cancer

By Mourabit Halima 2024.01.18

Editor's Note: The European Society for Medical Oncology (ESMO), as a globally renowned academic conference in the field of oncology, announces numerous cutting-edge developments each year. The ESMO 2023 annual…

Application of high-throughput next-generation sequencing in diagnosis and treatment of myeloid hematologic malignancies in the era of precision medic

By Mourabit Halima 2024.01.18

In May 2023, Professor Jun Ma and his team from Harbin Institute of Hematology Oncology published a paper in the Journal of Leukemia & Lymphoma titled "Application of high-throughput next-generation…

ESMO Expert Commentary | Dr. Yao Zhu: Success or Failure Does Not Define a Hero, Numerous Prostate Cancer Studies Aid in Optimizing Patient Survival

By Mourabit Halima 2024.01.17

Editor's Note: Prostate cancer is the leading male urological tumor in China and has become one of the fastest-growing male malignancies in the past decade. The recent ESMO conference unveiled…

ESMO China Voice | Professor Bin Shao : Comprehensive Genomic Analysis of Advanced HR+/HER2- Breast Cancer Patients Using Liquid Biopsy

By Peng Longmei 2024.01.17

Editor's Note: HR+/HER2- is the most common subtype of breast cancer, accounting for approximately 65% to 70% of all breast cancer cases. Improving the survival benefits for patients with advanced…

AASLD 2023 Highlights: Conference Overview and Special Topics Collection

By Mourabit Halima 2024.01.16

Editor's Note: From November 10th to 14th, the annual grand event in the field of hepatology, the American Association for the Study of Liver Diseases (AASLD) Annual Meeting 2023, is…

AASLD Hot Updates on MASLD from the 2023 Annual Meeting

By Kenzy Nour 2024.01.16

Editor's Note: On November 7, 2023, at 12:30 PM local time in Boston, the American Association for the Study of Liver Diseases (AASLD) held its sole pre-conference press briefing on…

AASLD Exclusive Interview | Dr.Mark Yarchoan: Progress in the Treatment of Intermediate and Advanced HCC, Highlighting the Value of Systemic Therapy

By El Bachir MOURABIT 2024.01.16

Editor's Note: At the recently concluded international annual flagship event in the field of hepatology – the American Association for the Study of Liver Diseases Annual Meeting (AASLD 2023), Professor…

Dr. Nigel Russell: The Latest International Treatment Advances in Acute Myeloid Leukemia

By Mourabit Halima 2024.01.14

Abstract: Dr. Nigel Russell provides insights into the recent developments in the treatment landscape of Acute Myeloid Leukemia (AML). The discussion encompasses the combination of FLT3 mutation inhibitors with intensive…

APASL 2023 | Prof. Hu Jinhua: Liver Cell Regeneration and Its Application in Liver Failure Treatment

By Peter W. PENG 2024.01.04

Editor's Note: At the 32nd Asia-Pacific Association for the Study of the Liver (APASL) annual conference, Professor Hu Jin-Hua from the Department of Hepatology at the Fifth Medical Center of…